Lung cancer surgery with removal of lymph nodes on the other side
Part of Cancer, Lungs & breathing clinical trials.
This study looks at whether removing lymph nodes from the opposite side of the chest during surgery can help people with advanced lung cancer that has spread to the lymph nodes in the middle of the chest. It may offer a more thorough treatment for patients who are healthy enough for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed type of lung cancer called non-small cell lung cancer (NSCLC), such as adenocarcinoma, squamous cell carcinoma, or large cell carcinoma.
- A PET-CT scan must show that the cancer has spread to lymph nodes on the opposite side of the chest (this is called N3 stage).
- You should be between 18 and 75 years old.
- Your heart and lungs must be healthy enough for major surgery, with good heart function (LVEF of 45% or higher) and lung function (FEV1 of 50% or more of predicted).
- The tumor must be removable by surgery, with no signs of spread to other parts of the body like the liver, bones, or brain.
- You must be in good overall health, able to do daily activities on your own (ECOG score 0 or 1), and willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This trial compares two ways of doing lung cancer surgery for early-stage tumors in the left lung. Some participants will have more lymph nodes removed (station 4L) and others will not, to see if the extra removal helps prevent the cancer from coming back.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
This study compares two types of lung cancer surgery for early-stage tumors: removing only the part of the lung with the tumor (segmentectomy) versus removing the entire lobe (lobectomy). It aims to see if the smaller surgery works just as well and might be easier to recover from.
This trial tests whether combining chemo or targeted therapy before surgery can help people with non-small cell lung cancer that may require removing a whole lung. We want to see if this approach makes the surgery safer and more effective.
This study tests a new way to decide which lymph nodes to remove during lung cancer surgery. The goal is to make surgery more precise and reduce side effects while still effectively removing cancer.
Hear when a new NSCLC, Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.